Prognostic value of CHA2DS2-VASc score in patients with 'non-valvular atrial fibrillation' and valvular heart disease: the Loire Valley Atrial Fibrillation Project.

PubWeight™: 0.77^‹?›

🔗 View Article (PMID 25994754)

Published in Eur Heart J on May 20, 2015

Authors

Raphael Philippart¹, Anne Brunet-Bernard¹, Nicolas Clementy¹, Thierry Bourguignon¹, Alain Mirza¹, Dominique Babuty¹, Denis Angoulvant¹, Gregory Y H Lip², Laurent Fauchier³

Author Affiliations

1: Service de Cardiologie, Centre Hospitalier Universitaire Trousseau et Faculté de Médecine, Université François Rabelais, Tours 37044, France.
2: University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham B18 7QH, UK.
3: Service de Cardiologie, Centre Hospitalier Universitaire Trousseau et Faculté de Médecine, Université François Rabelais, Tours 37044, France lfau@med.univ-tours.fr.

Articles citing this ↘

Prognosis in patients with atrial fibrillation and a presumed "temporary cause" in a community-based cohort study. Clin Res Cardiol (2016) 0.75

Articles by these authors ⇆

Stroke and bleeding risk assessment in atrial fibrillation: when, how, and why? Eur Heart J (2012) 1.04

Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis. Eur Heart J (2015) 0.90

Difficult decision making in the management of patients with atrial fibrillation and acute coronary syndrome or invasive cardiovascular interventions: new recommendations for daily practice. Europace (2015) 0.75

The atrial fibrillation epidemic: a validated diagnosis, or not? Europace (2014) 0.75